Favorable demographics,\u00a0such as an aging population and rising osteoarthritis cases, increased patient awareness, improved physician training, effective marketing efforts by companies, and ongoing product innovation will contribute to the\u00a0modest\u00a0growth in the\u00a0HA\u00a0viscosupplementation market. Although\u00a0alternative treatments are gaining traction, emerging clinical evidence supporting the efficacy of\u00a0HA\u00a0viscosupplementation in reducing pain associated with osteoarthritis will\u00a0support\u00a0HA\u00a0viscosupplementation market growth. Furthermore, premium-priced 1-injection products will continue to become more popular over the forecast period due to their convenience, whereas 3 and 5-injection products will continue to be preferred in some countries due to differences in product access, cost, and reimbursement.<\/p>\n
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for\u00a0HA\u00a0viscosupplementation in the US, Europe, Asia Pacific, and Brazil from 2019 through 2033.<\/p>\n","protected":false},"template":"","class_list":["post-584583","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-date-983"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/584583","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=584583"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}